(MSPR) MSP Recovery - Ratings and Ratios
Claims, Recovery, Data, Analytics, Healthcare
MSPR EPS (Earnings per Share)
MSPR Revenue
Description: MSPR MSP Recovery
MSP Recovery Inc, operating as LifeWallet, is a pioneering healthcare recovery and data analytics company revolutionizing the US and Puerto Rico healthcare landscape. By leveraging its proprietary data ecosystem, LifeWallet, the company provides a suite of innovative solutions, including claims recovery services, electronic health records (EHR) management, and real-time analytics-driven platforms. This enables healthcare providers, laboratories, and governmental entities to optimize their operations, while also facilitating the identification of proper primary payers at the point of care.
The companys multifaceted platform, comprising LifeWallet EHR, Chase to Pay, LifeChain, and forthcoming LifeWallet911, is designed to streamline healthcare data management, enhance patient-centric care, and unlock new revenue streams. Additionally, LifeWallets foray into emerging markets, such as LifeWallet Sports, which connects brands with college athletes, underscores its commitment to diversification and growth. With a strong foundation established since its inception in 2014, MSP Recovery Inc is poised to capitalize on the burgeoning healthcare data analytics market.
Analyzing the
Forecasting MSPRs price movement, we can expect the stock to face resistance at $1.73 (SMA50) in the short term. A break above this level could propel the stock towards $2.50, driven by the companys expanding product portfolio and increasing market penetration. Conversely, a decline below $1.38 (SMA200) may signal a more significant correction, potentially targeting $1.00. Investors should closely monitor MSPRs price action, as a sustained move above or below these key levels will be crucial in determining the stocks near-term trajectory.
Additional Sources for MSPR Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
MSPR Stock Overview
Market Cap in USD | 8m |
Sector | Healthcare |
Industry | Health Information Services |
GiC Sub-Industry | Property & Casualty Insurance |
IPO / Inception | 2020-10-21 |
MSPR Stock Ratings
Growth Rating | -61.3 |
Fundamental | - |
Dividend Rating | 0.0 |
Rel. Strength | 178 |
Analysts | 5 of 5 |
Fair Price Momentum | 0.57 USD |
Fair Price DCF | - |
MSPR Dividends
Currently no dividends paidMSPR Growth Ratios
Growth Correlation 3m | -91.5% |
Growth Correlation 12m | 49.9% |
Growth Correlation 5y | -88.7% |
CAGR 5y | -68.34% |
CAGR/Max DD 5y | -0.68 |
Sharpe Ratio 12m | -0.18 |
Alpha | 34.29 |
Beta | 9.990 |
Volatility | 904.71% |
Current Volume | 4.1k |
Average Volume 20d | 4.3k |
Stop Loss | 1 (-3.8%) |
As of July 13, 2025, the stock is trading at USD 1.04 with a total of 4,075 shares traded.
Over the past week, the price has changed by +3.56%, over one month by -28.98%, over three months by -60.73% and over the past year by +158.93%.
No, based on ValueRay´s Analyses, MSP Recovery (NASDAQ:MSPR) is currently (July 2025) a stock to sell. It has a ValueRay Growth Rating of -61.25 and therefor a clear technical negative rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of MSPR is around 0.57 USD . This means that MSPR is currently overvalued and has a potential downside of -45.19%.
MSP Recovery has received a consensus analysts rating of 5.00. Therefore, it is recommended to buy MSPR.
- Strong Buy: 1
- Buy: 0
- Hold: 0
- Sell: 0
- Strong Sell: 0
According to our own proprietary Forecast Model, MSPR MSP Recovery will be worth about 0.6 in July 2026. The stock is currently trading at 1.04. This means that the stock has a potential downside of -40.38%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | 3 | 188.5% |
Analysts Target Price | 3 | 188.5% |
ValueRay Target Price | 0.6 | -40.4% |